2023
DOI: 10.1002/ccr3.6810
|View full text |Cite
|
Sign up to set email alerts
|

A novel RAD51 variant resulting in Fanconi anemia identified in an infant with multiple congenital anomalies

Abstract: Fanconi anemia (FA) is a rare genetic condition associated with pathogenic variants of several genes involved in DNA repair. Clinically, FA can present at birth with multiple congenital anomalies and growth restriction, and progresses over time with bone marrow failure and increased risk of malignancy. The average age of onset of bone marrow failure is 7.6 years, with a cumulative probability of occurrence of 90% by age 40 years. 1 The risk of developing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 6 publications
0
3
0
Order By: Relevance
“…Whereas three pathogenic variants in RAD51 have been reported in four cases of an atypical form of FA (FA-R) ( Table 1 ), no cancer predisposition has been associated with these RAD51 mutations to date (cases reported at <4 months and 13, 23, and 9 years of age). This contrasts with the other HR genes mutated in FA [ 22 , 23 , 24 , 25 ]. Collectively, because RAD51 behaves differently than its mediator/accessory proteins for cancerous predisposition, despite its central role in HR, these data reveal the “RAD51 paradox” [ 13 ].…”
Section: Introductionmentioning
confidence: 80%
See 1 more Smart Citation
“…Whereas three pathogenic variants in RAD51 have been reported in four cases of an atypical form of FA (FA-R) ( Table 1 ), no cancer predisposition has been associated with these RAD51 mutations to date (cases reported at <4 months and 13, 23, and 9 years of age). This contrasts with the other HR genes mutated in FA [ 22 , 23 , 24 , 25 ]. Collectively, because RAD51 behaves differently than its mediator/accessory proteins for cancerous predisposition, despite its central role in HR, these data reveal the “RAD51 paradox” [ 13 ].…”
Section: Introductionmentioning
confidence: 80%
“…However, the more recent discovery of two non-truncating RAD51 variants (i.e., p.R250Q and p.T134N) [ 26 , 27 ] raised the possibility of alternative pathogenic mechanisms. Molecular pathogenesis may provide insight into the link between the molecular defect and the discrete phenotypes related to human RAD51 mutations, namely, atypical Fanconi anemia (FA-R) [ 22 , 23 , 24 , 25 ], premature ovarian insufficiency [ 30 ], and CMM ( Table 1 and Figure 7 ). No cancer predisposition has been reported in the pathologies caused by RAD51 variants ( Table 1 ).…”
Section: Rad51 Pathogenic Variants In Congenital Mirror Move...mentioning
confidence: 99%
“…Although RAD51 has historically been recognized as a key recombinase in the strand exchange process during HR, four heterozygous RAD51 mutations— RAD51-T131P , RAD51-A293T , RAD51-Q242R , and RAD51-A294T —have recently been found to cause an FA-like phenotype, designated as FANCR ( 26 , 27 , 28 , 29 , 30 ). Patient-derived cells with these mutations showed hypersensitivity to crosslinking agents.…”
mentioning
confidence: 99%